Aleksandra K Drelich

5PUBLICATIONS
40CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursMolecular medicineCheminformatics and quantitative structure-activity relationshipsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 05, 2025
Rapid restoration of potent neutralization activity against the latest Omicron variant JN.1 via AI rational design and antibody engineering.

Yunji Liao, Hang Ma, Zhenyu Wang

|Jun 24, 2024
Characterization of Unique Pathological Features of COVID-Associated Coagulopathy: Studies with AC70 hACE2 Transgenic Mice Highly Permissive to SARS-CoV-2 Infection.

Aleksandra K Drelich, Kempaiah Rayavara, Jason Hsu

|Mar 13, 2024
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations.

Michael Westberg, Yichi Su, Xinzhi Zou

|Feb 18, 2021
Bepridil is potent against SARS-CoV-2 in vitro.

Erol C Vatansever, Kai S Yang, Aleksandra K Drelich

|Nov 03, 2020
Rapid identification of a human antibody with high prophylactic and therapeutic efficacy in three animal models of SARS-CoV-2 infection.

Wei Li, Chuan Chen, Aleksandra Drelich

Pageof 1

Frequent Collaborators

4 joint publications

Chien-Te K Tseng

2 joint publications

Bi-Hung Peng

2 joint publications

Vivian Tat

2 joint publications

Dimiter S Dimitrov